कोशिश गोल्ड - मुक्त

The American Investor Taking On Swatch's Founding Family

Mint Hyderabad

|

June 19, 2025

Wood published research that shows that family-owned businesses outperform the market over time

- Margot Patrick

When American fund manager Steven Wood set his sights on the storied Swiss watchmaker Swatch Group, he tried a suitably stylish opening gambit. He sent Chief Executive Nick Hayek cigars; a favorite book, "The Luxury Strategy" by Jean-Noël Kapferer and Vincent Bastien; and a handwritten note laying out opportunities he saw for Swatch's luxury brands to recapture market share.

Over coffee, Wood says they discussed marketing strategies, particularly for the high-end brands, and how the company, known for its minimal contact with investors, should share more information.

Wood swapped out a Patek Philippe as his everyday watch in favor of a secondhand Breguet Classique. Within days of the October meeting, he invested more than one-quarter of his $150 million fund into the Swiss company, for around a 0.5% stake.

But the courtship abruptly ended in March, when Wood submitted himself as a board candidate to represent Swatch's minority shareholders.

Sales at Swatch had grown for years thanks to the popularity of its chic brands like Breguet, Blancpain and Omega, but since founder Nicolas G. Hayek's death in 2010, its high-end offerings have lost market share. Last year sales plunged in China, one of its most important markets, and the company's stock is now one of the most-shorted in Europe.

Wood, who runs investment firm GreenWood Investors, reached out to Nick Hayek, the founder's son, in September. The next month, the New York-based investor secured a meeting with the CEO and the finance chief at Swatch's timber-framed headquarters in Biel, Switzerland, where they talked for more than two hours

Mint Hyderabad से और कहानियाँ

Mint Hyderabad

Mint Hyderabad

Nvidia, Eli Lilly to invest $1 bn in AI lab

Nvidia Corp. plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., aiming to speed up the use of artificial intelligence (AI) in the pharmaceutical industry.

time to read

1 min

January 13, 2026

Mint Hyderabad

Shadowfax IPO to open next week

Logistics services provider Shadowfax is set to launch its ₹1,900-crore initial public offering (IPO) next week, targeting a valuation of ₹7,400 crore, people familiar with the matter said on Monday.

time to read

1 min

January 13, 2026

Mint Hyderabad

The US climate cop-out should galvanize others

America's withdrawal from the global battle against climate change is a signal for the rest of the world to unite for the greater good. The cause is vital, not the participation of the US

time to read

2 mins

January 13, 2026

Mint Hyderabad

Toyota pushes for fuel norm clarity

The government should soon come out with the final notification for the next phase of India’s Corporate Average Fuel Efficiency standards so that the industry can prepare accordingly, according to a senior Toyota Kirloskar Motor executive.

time to read

1 min

January 13, 2026

Mint Hyderabad

Food effect lifts Dec CPI inflation

India's retail inflation rose for the second successive month in December, data released by the statistics ministry on Monday showed, driven by a moderation in negative food inflation and an uptick in core inflation.

time to read

1 min

January 13, 2026

Mint Hyderabad

Mint Hyderabad

Commissions trump advice in wealth management biz

surge on rising affluence, strong economic growth, higher foreign direct investments, and the growth of the startup ecosystem.

time to read

2 mins

January 13, 2026

Mint Hyderabad

The Chinese company taking on the world's memory-chip giants

As AI demand drives prices up, CXMT beats Washington's curbs to vie with Micron and South Korean leaders

time to read

4 mins

January 13, 2026

Mint Hyderabad

HC lifts ban on Zydus cancer biosimilar till patent expiry

In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anticancer drug nivolumab in India, citing public interest.

time to read

2 mins

January 13, 2026

Mint Hyderabad

Fix GST on capital goods to revive private investment

India faces a paradox today.

time to read

3 mins

January 13, 2026

Mint Hyderabad

Mint Hyderabad

Feeling tired? It could be too many messages

The cumulative stress of constant notifications is leaving many emotionally burnt out. Tackling it requires small, sustainable changes

time to read

4 mins

January 13, 2026

Listen

Translate

Share

-
+

Change font size